During the global pandemic, the world saw firsthand how essential clinical trials were in developing medicines to improve health and extend human life. Clinical research sites, including academic medical centers (AMC), non-AMCs and professional…
Continue Reading
What You Should Know: Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage…
Continue Reading
NHSE’s procurement for the Federated Data Platform and award of a £330m contract is story that has stretched over more than three years, to the start of the Covid-19 pandemic, during which time Palantir has become…
Continue Reading
Margaret Anderson, Managing Director at Deloitte Consulting LLP
In response to the COVID-19 pandemic, the biomedical community took on the task of developing and deploying critical interventions to address an unprecedented public health emergency. In…
Continue Reading
Researchers at MIT have developed an enhanced mRNA vaccine system that can elicit a greater immune response at lower doses. The vaccine technology is so potent that it may be useful for intranasal COVID-19…
Continue Reading
Clinical informaticists are often asked to help their organizations with strategies to combat health misinformation, whether it’s through implementing patient education solutions, providing input for patient-facing websites, consulting on social media campaigns, or creating…
Continue Reading
Kate Behan, MD, FACP, Chief Medical Officer, Arcadia
A so-called “tripledemic” — the convergence of flu, RSV and COVID-19 — led to significant morbidity and mortality, and it also forced the cancellation or delay of…
Continue Reading
Updated COVID-19 vaccines should be available soon, following approvals by the US Food and Drug Administration and the Centers for Disease Control and Prevention. They’re recommended for everyone age six months and older, so…
Continue Reading
Tel Aviv-based AI-enabled computational protein engineering platform Scala Biodesign announced its launch today with $5.5 million in seed funding.The round was led by TLV Partners, an Israeli venture capital firm that invests in early-stage…
Continue Reading
New Zealand’s Centre for Adverse Reactions Monitoring is now transitioning to a new digital system for collecting and storing adverse drug reaction reports in the country, retiring its almost 60-year-old database.The centre has worked…
Continue Reading
